Skip to content
ppharmaranks
Menu

PANWARFIN vs PRADAXA

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 23, 2026·How we rate

Possible drug interaction. PANWARFIN and PRADAXA are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Rating

70/100
72/100

Pharmacy pays

~$2.58 /30
~$27.04 /30

Type

RX
RX

Active ingredient

WARFARIN SODIUM
DABIGATRAN ETEXILATE MESYLATE

Dosage forms

Tablet
Capsule, Oral pellets

Drug class

Vitamin K Antagonist
Direct Thrombin Inhibitor

Boxed warning

Half-life

about 40 hours (the label's effective half-life; range 20 to 60 hours)

Treats

Atrial Fibrillation, Postoperative Complications, Pulmonary Embolism
Pulmonary Embolism, Venous Thrombosis

Frequently asked questions

Which is better-rated, Panwarfin or Pradaxa?

By our independent rating, Pradaxa scores higher — 3.6 vs 3.5 out of 5 for Panwarfin. Ratings are based on FDA regulatory (recall-safety) data.

Which is cheaper, Panwarfin or Pradaxa?

Panwarfin costs pharmacies less to acquire — about $2.58 vs $27.04 for a 30-count supply, per the CMS NADAC survey. That gap is in the pharmacy's cost of goods, not necessarily in what you pay: your price is set afterwards by your insurer and the pharmacy.

What is the difference between Panwarfin and Pradaxa?

Panwarfin contains Warfarin Sodium, while Pradaxa contains Dabigatran Etexilate Mesylate — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.